,reactionmeddraversionpt,reactionmeddrapt,safetyreportid,reactionoutcome
0,22.1,Diarrhoea,17241673,
0,22.1,Hypertension,17241747,
0,22.1,Thrombosis,17241755,
0,22.1,Anaemia,17241772,
1,22.1,Packed red blood cell transfusion,17241772,
2,22.1,Haematochezia,17241772,
3,22.1,Vascular device user,17241772,
0,22.1,Cellulitis,17241801,
0,22.1,Transfusion,17241943,
0,22.1,Fatigue,17241964,
1,22.1,Alopecia,17241964,
0,22.1,Death,17242071,
0,22.1,Fatigue,17242180,
1,22.1,Decreased appetite,17242180,
2,22.1,Pneumonia,17242180,
3,22.1,Weight decreased,17242180,
4,22.1,Asthenia,17242180,
5,22.1,Diarrhoea,17242180,
0,22.1,Pain in extremity,17242334,
0,22.1,Loss of consciousness,17242613,
1,22.1,Fall,17242613,
2,22.1,Seizure,17242613,
3,22.1,Ketoacidosis,17242613,
4,22.1,Blood electrolytes normal,17242613,
5,22.1,Renal failure,17242613,
6,22.1,Blood glucose increased,17242613,
7,22.1,Joint dislocation,17242613,
0,22.1,Nausea,17242702,
0,22.1,Sensation of foreign body,17242723,
1,22.1,Dysphagia,17242723,
2,22.1,Dyspepsia,17242723,
0,22.1,Ulcer,17242730,
0,22.1,Therapy cessation,17242885,
1,22.1,Hospitalisation,17242885,
0,22.1,Thrombosis,17242929,
0,22.1,Therapy cessation,17243194,
1,22.1,Palmar-plantar erythrodysaesthesia syndrome,17243194,
0,22.1,Neuropathy peripheral,17243279,
1,22.1,Oedema,17243279,
0,22.1,Death,17243284,
0,22.1,Lethargy,17243354,
1,22.1,Jaundice,17243354,
2,22.1,Pneumonia,17243354,
3,22.1,Failure to thrive,17243354,
0,22.1,Alopecia,17245741,
1,22.1,Arthralgia,17245741,
0,22.1,Disease progression,17245742,
0,22.1,Skin discolouration,17245746,
0,22.1,Fatigue,17246730,
1,22.1,Diarrhoea,17246730,
0,22.1,Hepatic enzyme increased,17246772,
1,22.1,Therapy cessation,17246772,
0,22.1,Visual impairment,17246826,
0,22.1,Alopecia,17247050,
0,22.1,Nasopharyngitis,17247446,
1,22.1,Cough,17247446,
0,22.1,Diarrhoea,17247461,
0,22.1,Nausea,17247514,
0,22.1,Alopecia,17247528,
0,22.1,Pruritus,17247533,
1,22.1,Skin discolouration,17247533,
0,22.1,Diarrhoea,17247585,
1,22.1,Pain,17247585,
2,22.1,Haemorrhoids,17247585,
0,22.1,Epistaxis,17247590,
1,22.1,Nasal dryness,17247590,
0,22.1,Vulvovaginal mycotic infection,17247634,
1,22.1,Urinary tract infection,17247634,
2,22.1,Vulvovaginal discomfort,17247634,
3,22.1,Vulvovaginal pain,17247634,
0,22.1,Pain,17247927,
0,22.1,Erythema,17247934,
1,22.1,Therapy change,17247934,
0,22.1,Pruritus,17250601,
1,22.1,Pain in extremity,17250601,
0,22.1,Inappropriate schedule of product administration,17250697,
0,22.1,Sciatica,17250768,
1,22.1,Therapy cessation,17250768,
0,22.1,Arthralgia,17250835,
1,22.1,Insomnia,17250835,
0,22.1,Off label use,17250921,
0,22.1,Skin exfoliation,17252170,
1,22.1,Haemorrhoids,17252170,
2,22.1,Stomatitis,17252170,
3,22.1,Asthenia,17252170,
4,22.1,Pruritus,17252170,
0,22.1,Anaemia,17155325,6
0,22.1,Hyperglycaemia,17155334,2
0,22.1,Drug ineffective,17155348,6
0,22.1,Metastases to meninges,17155511,6
1,22.1,Paraparesis,17155511,6
2,22.1,Dermatitis,17155511,6
3,22.1,Inappropriate antidiuretic hormone secretion,17155511,6
4,22.1,Malignant neoplasm progression,17155511,6
5,22.1,Death,17155511,5
6,22.1,Delirium,17155511,6
7,22.1,Hypokalaemia,17155511,6
8,22.1,Fatigue,17155511,6
9,22.1,Blood sodium decreased,17155511,6
10,22.1,Leukopenia,17155511,6
0,22.1,Fatigue,17155520,6
1,22.1,Diarrhoea,17155520,6
2,22.1,Dysgeusia,17155520,6
0,22.1,Abdominal pain,17155530,6
1,22.1,Fatigue,17155530,6
0,22.1,Drug ineffective,17155566,6
0,22.1,Nausea,17155705,6
1,22.1,Diarrhoea,17155705,6
0,22.1,Energy increased,17155758,6
1,22.1,Pulmonary embolism,17155758,6
0,22.1,Laryngeal oedema,17155816,3
1,22.1,Condition aggravated,17155816,3
2,22.1,Dysphagia,17155816,3
0,22.1,Prostate cancer,17155902,6
1,22.1,Dehydration,17155902,6
2,22.1,Hypothyroidism,17155902,6
3,22.1,Type 2 diabetes mellitus,17155902,6
4,22.1,Cerebrovascular accident,17155902,4
5,22.1,Hypertension,17155902,6
0,22.1,Pain,17155908,6
0,22.1,Liver disorder,17155938,3
0,22.1,Death,17156000,5
0,22.1,Rash,17156009,6
1,22.1,Nausea,17156009,6
2,22.1,Stomatitis,17156009,6
3,22.1,Dyspepsia,17156009,6
4,22.1,Fatigue,17156009,6
0,22.1,Rash,17156023,1
0,22.1,Colitis,17156033,6
0,22.1,Electrocardiogram QT prolonged,17156114,6
1,22.1,Weight decreased,17156114,6
2,22.1,Syncope,17156114,6
0,22.1,Malignant neoplasm progression,17156123,5
1,22.1,Infection,17156123,5
2,22.1,Cholestasis,17156123,5
0,22.1,Therapy non-responder,17156133,6
1,22.1,Malignant neoplasm progression,17156133,6
0,22.1,Fatigue,17156164,3
1,22.1,White blood cell count decreased,17156164,6
2,22.1,Leukopenia,17156164,6
3,22.1,Dizziness,17156164,6
4,22.1,Neuropathy peripheral,17156164,1
5,22.1,Paraesthesia,17156164,3
0,22.1,Diarrhoea,17156188,6
1,22.1,Escherichia infection,17156188,6
0,22.1,Gastric ulcer,17156206,3
1,22.1,Cough,17156206,3
2,22.1,Gastric disorder,17156206,3
3,22.1,Hypoaesthesia,17156206,3
4,22.1,Abdominal pain upper,17156206,3
0,22.1,Haemorrhagic diathesis,17156231,6
1,22.1,Pyrexia,17156231,6
2,22.1,Neoplasm progression,17156231,3
3,22.1,Fatigue,17156231,6
4,22.1,Paraesthesia,17156231,6
5,22.1,Anaemia,17156231,6
6,22.1,Abdominal distension,17156231,6
7,22.1,Urinary retention,17156231,6
8,22.1,Headache,17156231,6
9,22.1,Weight decreased,17156231,6
0,22.1,Pneumonia,17156289,1
0,22.1,Abdominal discomfort,17156308,3
1,22.1,Dizziness,17156308,6
2,22.1,Nausea,17156308,6
3,22.1,Asthenia,17156308,6
4,22.1,Calculus urinary,17156308,6
5,22.1,Contusion,17156308,6
6,22.1,Fatigue,17156308,3
7,22.1,Nephrolithiasis,17156308,6
8,22.1,Product dose omission,17156308,6
9,22.1,Urinary tract infection,17156308,6
10,22.1,Diarrhoea,17156308,1
11,22.1,Abdominal pain upper,17156308,3
0,22.1,Lip swelling,17156314,1
1,22.1,Lip pain,17156314,1
2,22.1,Infusion related reaction,17156314,1
0,22.1,Therapy partial responder,17156335,6
1,22.1,Atypical haemolytic uraemic syndrome,17156335,6
2,22.1,Thrombosis,17156335,6
0,22.1,Death,17156357,5
0,22.1,Asthenia,17156378,3
1,22.1,Haematuria,17156378,1
2,22.1,General physical health deterioration,17156378,6
0,22.1,Intracranial mass,17156460,6
1,22.1,Autoimmune disorder,17156460,6
2,22.1,Nervous system disorder,17156460,1
3,22.1,Seizure,17156460,6
4,22.1,Brain midline shift,17156460,6
5,22.1,Demyelination,17156460,6
0,22.1,Fatigue,17156474,6
1,22.1,Nausea,17156474,6
0,22.1,Ileus,17156498,6
1,22.1,Diarrhoea,17156498,6
0,22.1,Muscular weakness,17156523,2
1,22.1,Arthralgia,17156523,2
2,22.1,Musculoskeletal toxicity,17156523,2
3,22.1,Myalgia,17156523,2
4,22.1,Asthenia,17156523,2
5,22.1,Drug interaction,17156523,6
6,22.1,Toxicity to various agents,17156523,2
7,22.1,Rhabdomyolysis,17156523,2
8,22.1,Myopathy,17156523,2
9,22.1,Pain in extremity,17156523,2
0,22.1,Haemoptysis,17156620,5
0,22.1,Coronary artery disease,17156626,5
1,22.1,Septic shock,17156626,5
2,22.1,Chronic obstructive pulmonary disease,17156626,3
3,22.1,Respiratory failure,17156626,3
4,22.1,Hypercapnia,17156626,3
5,22.1,Clostridium colitis,17156626,5
6,22.1,Drug ineffective,17156626,6
7,22.1,Acute kidney injury,17156626,3
0,22.1,Death,17156627,5
0,22.1,Neutropenia,17156629,1
0,22.1,Leukopenia,17156667,1
1,22.1,Malignant neoplasm progression,17156667,5
2,22.1,Mucosal inflammation,17156667,1
0,22.1,Product use in unapproved indication,17156677,6
1,22.1,Fatigue,17156677,3
2,22.1,Pyrexia,17156677,3
0,22.1,Toxicity to various agents,17156709,6
1,22.1,Cardiotoxicity,17156709,6
0,22.1,Device related infection,17156721,1
0,22.1,Postoperative wound infection,17156722,6
0,22.1,Myalgia,17156765,2
1,22.1,Arthralgia,17156765,2
2,22.1,Myopathy,17156765,2
3,22.1,Rhabdomyolysis,17156765,2
4,22.1,Asthenia,17156765,2
5,22.1,Drug interaction,17156765,6
6,22.1,Muscular weakness,17156765,2
7,22.1,Musculoskeletal toxicity,17156765,2
8,22.1,Pain in extremity,17156765,2
0,22.1,Oxygen saturation decreased,17156770,1
1,22.1,Hypotension,17156770,1
2,22.1,Rash,17156770,1
3,22.1,Visual impairment,17156770,1
4,22.1,Pruritus,17156770,1
0,22.1,Anaphylactic shock,17156833,1
0,22.1,Musculoskeletal toxicity,17156868,2
1,22.1,Arthralgia,17156868,2
2,22.1,Asthenia,17156868,2
3,22.1,Pain in extremity,17156868,2
4,22.1,Myopathy,17156868,2
5,22.1,Rhabdomyolysis,17156868,2
6,22.1,Drug interaction,17156868,6
7,22.1,Myalgia,17156868,2
8,22.1,Muscular weakness,17156868,2
0,22.1,Maternal exposure during pregnancy,17156902,6
1,22.1,Cerebral haemorrhage neonatal,17156902,5
0,22.1,Dyspnoea,17156942,3
1,22.1,Death,17156942,5
0,22.1,Hypoglycaemia,17156945,6
1,22.1,Pneumonia aspiration,17156945,6
2,22.1,Cough,17156945,6
3,22.1,Aspergillus infection,17156945,5
0,22.1,Rash,17156964,1
1,22.1,Diarrhoea,17156964,1
2,22.1,Drug ineffective,17156964,3
0,22.1,Rash,17156971,1
1,22.1,Hypotension,17156971,1
2,22.1,Pruritus,17156971,1
3,22.1,Visual impairment,17156971,1
4,22.1,Oxygen saturation decreased,17156971,1
0,22.1,Colitis,17157003,1
1,22.1,Polyneuropathy,17157003,1
2,22.1,Fatigue,17157003,1
0,22.1,Bacterial sepsis,17157099,6
0,22.1,Epilepsy,17157124,1
0,22.1,Skin disorder,17157127,2
0,22.1,Disease progression,17157143,6
0,22.1,Pancytopenia,17157152,1
0,22.1,Haemophagocytic lymphohistiocytosis,17157163,3
1,22.1,Hyperferritinaemia,17157163,3
2,22.1,Pancytopenia,17157163,3
3,22.1,Pyrexia,17157163,3
4,22.1,Hypertriglyceridaemia,17157163,3
5,22.1,Off label use,17157163,6
0,22.1,Colitis,17157196,4
1,22.1,Diarrhoea,17157196,4
2,22.1,Off label use,17157196,6
0,22.1,Off label use,17157198,6
1,22.1,Septic shock,17157198,1
2,22.1,Neutropenic colitis,17157198,1
0,22.1,Hypothermia,17157215,6
1,22.1,Muscular weakness,17157215,6
2,22.1,Erysipelas,17157215,3
3,22.1,Alopecia,17157215,3
4,22.1,Decreased immune responsiveness,17157215,3
5,22.1,Rash pruritic,17157215,3
0,22.1,Drug interaction,17157224,1
1,22.1,Hepatic function abnormal,17157224,1
0,22.1,Malignant neoplasm progression,17157269,5
1,22.1,Intentional product use issue,17157269,6
0,22.1,Ileus,17157271,6
1,22.1,Necrotising colitis,17157271,6
0,22.1,Interstitial lung disease,17157291,5
1,22.1,Femur fracture,17157291,1
2,22.1,Fall,17157291,6
0,22.1,Thrombocytopenia,17157308,2
1,22.1,Melaena,17157308,6
0,22.1,Daydreaming,17157313,1
0,22.1,Vasculitis,17157318,5
1,22.1,Neutropenia,17157318,5
2,22.1,Renal failure,17157318,5
0,22.1,Acute lymphocytic leukaemia,17157333,6
0,22.1,Death,17157343,5
1,22.1,Toxicity to various agents,17157343,5
0,22.1,Tumour haemorrhage,17157347,3
1,22.1,Fall,17157347,6
2,22.1,Somnolence,17157347,6
3,22.1,Metastases to central nervous system,17157347,3
4,22.1,Colon cancer,17157347,6
5,22.1,Depressed level of consciousness,17157347,6
0,22.1,Skin infection,17157369,2
0,22.1,Off label use,17157373,6
1,22.1,Diarrhoea,17157373,5
2,22.1,Renal failure,17157373,5
3,22.1,Neutropenia,17157373,5
4,22.1,Hyperglycaemia,17157373,5
5,22.1,Fatigue,17157373,5
0,22.1,Back pain,17157376,1
1,22.1,Cyanosis,17157376,1
2,22.1,Hypersensitivity,17157376,1
3,22.1,Dyspnoea,17157376,1
4,22.1,Erythema,17157376,1
0,22.1,Back pain,17157388,2
0,22.1,Liver function test increased,17157399,6
1,22.1,Disease progression,17157399,2
2,22.1,Blood bilirubin increased,17157399,6
3,22.1,Tinnitus,17157399,6
4,22.1,Metastases to liver,17157399,2
5,22.1,Headache,17157399,6
6,22.1,Nausea,17157399,6
7,22.1,Haematotoxicity,17157399,2
8,22.1,Metastases to central nervous system,17157399,6
0,22.1,Malignant neoplasm progression,17157401,6
0,22.1,Cardiac arrest,17157442,5
0,22.1,Malignant neoplasm progression,17157463,6
0,22.1,Cardio-respiratory arrest,17157485,5
0,22.1,Disseminated intravascular coagulation,17157518,6
1,22.1,Serratia infection,17157518,6
2,22.1,Aortic valve stenosis,17157518,5
3,22.1,Post procedural sepsis,17157518,5
0,22.1,Dyspnoea,17157660,3
0,22.1,Memory impairment,17157684,6
1,22.1,Fall,17157684,6
2,22.1,Tachycardia,17157684,6
3,22.1,Pneumonia,17157684,6
4,22.1,Dyspnoea,17157684,6
5,22.1,Cardiac disorder,17157684,6
6,22.1,Product dose omission,17157684,6
7,22.1,Myalgia,17157684,6
0,22.1,Pyrexia,17157690,3
1,22.1,Influenza,17157690,3
2,22.1,Acne,17157690,6
3,22.1,Yellow skin,17157690,6
4,22.1,Alopecia,17157690,6
5,22.1,Blood thyroid stimulating hormone increased,17157690,6
6,22.1,Pneumonia,17157690,6
7,22.1,Decreased appetite,17157690,6
0,22.1,Chills,17157716,2
1,22.1,Hypertension,17157716,2
2,22.1,Tachycardia,17157716,2
3,22.1,Wheezing,17157716,2
4,22.1,Pyrexia,17157716,2
0,22.1,Pericardial effusion,17157722,3
1,22.1,Pleural effusion,17157722,3
0,22.1,Breast cancer recurrent,17157728,6
0,22.1,Complication of device insertion,17157746,6
0,22.1,Atrial fibrillation,17157819,2
1,22.1,Tachycardia,17157819,2
2,22.1,Interstitial lung disease,17157819,2
0,22.1,Anaemia,17157832,6
1,22.1,Metastases to lymph nodes,17157832,6
2,22.1,Therapy partial responder,17157832,6
3,22.1,Bone marrow toxicity,17157832,6
4,22.1,Toxicity to various agents,17157832,6
5,22.1,Disease recurrence,17157832,6
6,22.1,Metastasis,17157832,6
7,22.1,Malignant neoplasm progression,17157832,6
8,22.1,Metastases to lung,17157832,6
0,22.1,Dermatitis,17157843,2
0,22.1,Ovarian failure,17157877,1
1,22.1,Amenorrhoea,17157877,1
0,22.1,Vomiting,17157909,6
1,22.1,Visual impairment,17157909,6
0,22.1,Onychoclasis,17157927,3
1,22.1,Hypoaesthesia,17157927,6
2,22.1,Paraesthesia,17157927,6
3,22.1,Nausea,17157927,3
4,22.1,Bronchitis,17157927,6
0,22.1,Pneumonitis,17157953,6
0,22.1,Pneumonitis,17157962,1
1,22.1,Malaise,17157962,6
0,22.1,Nausea,17157971,2
1,22.1,Blood pressure increased,17157971,6
2,22.1,Fatigue,17157971,3
3,22.1,Vomiting,17157971,2
4,22.1,Diarrhoea,17157971,6
5,22.1,Dysphagia,17157971,6
0,22.1,Hepatotoxicity,17157980,1
1,22.1,Neutropenia,17157980,1
2,22.1,Alanine aminotransferase abnormal,17157980,1
0,22.1,Hyponatraemia,17158071,2
1,22.1,Decreased appetite,17158071,3
2,22.1,Abdominal infection,17158071,5
3,22.1,Cachexia,17158071,3
4,22.1,Oedema peripheral,17158071,3
5,22.1,Salmonella sepsis,17158071,5
6,22.1,White blood cell count increased,17158071,3
7,22.1,Hypoalbuminaemia,17158071,3
8,22.1,Fatigue,17158071,1
9,22.1,Depression,17158071,3
0,22.1,Chills,17158108,1
1,22.1,Rash,17158108,1
2,22.1,Hypotension,17158108,1
3,22.1,Oxygen saturation decreased,17158108,1
4,22.1,Nausea,17158108,1
5,22.1,Pyrexia,17158108,1
6,22.1,Tachycardia,17158108,1
0,22.1,Rectal haemorrhage,17158149,6
1,22.1,Mouth haemorrhage,17158149,6
0,22.1,Anaemia,17158221,1
0,22.1,Atrial fibrillation,17158224,1
1,22.1,Prostatic specific antigen increased,17158224,3
2,22.1,Urinary tract infection,17158224,1
0,22.1,Blood urine present,17158226,6
1,22.1,Platelet count decreased,17158226,6
2,22.1,Protein urine present,17158226,6
0,22.1,Malignant neoplasm progression,17158238,6
1,22.1,Ill-defined disorder,17158238,6
2,22.1,Death,17158238,5
3,22.1,Eating disorder,17158238,6
4,22.1,Immunodeficiency,17158238,6
5,22.1,Vomiting,17158238,6
0,22.1,Rash,17158293,6
0,22.1,Haemoglobin decreased,17158306,6
1,22.1,Red blood cell count decreased,17158306,6
2,22.1,Neutrophil count decreased,17158306,6
0,22.1,Neutropenia,17158307,6
1,22.1,Neoplasm progression,17158307,6
0,22.1,Nasopharyngitis,17158308,6
0,22.1,Laboratory test abnormal,17158319,6
0,22.1,White blood cell count decreased,17158355,2
0,22.1,Stomatitis,17158365,3
1,22.1,Viral infection,17158365,6
2,22.1,Product dose omission,17158365,6
0,22.1,Condition aggravated,17158382,5
1,22.1,Pneumonia,17158382,3
2,22.1,Pulmonary embolism,17158382,3
3,22.1,Peripheral swelling,17158382,3
0,22.1,Renal impairment,17158436,6
0,22.1,Thyroid cancer,17158438,3
0,22.1,Gingival pain,17158458,1
1,22.1,Palmar-plantar erythrodysaesthesia syndrome,17158458,3
2,22.1,Protein urine present,17158458,3
3,22.1,Vomiting,17158458,1
4,22.1,Hyperaesthesia,17158458,1
5,22.1,Malaise,17158458,2
6,22.1,Nausea,17158458,1
7,22.1,Gingivitis,17158458,1
8,22.1,Diarrhoea,17158458,1
9,22.1,Myocardial infarction,17158458,1
10,22.1,Gingival swelling,17158458,1
11,22.1,Dysphonia,17158458,1
12,22.1,Alopecia,17158458,3
13,22.1,Taste disorder,17158458,1
14,22.1,Tooth loss,17158458,2
15,22.1,Decreased appetite,17158458,1
16,22.1,Angular cheilitis,17158458,1
17,22.1,Skin hypertrophy,17158458,3
18,22.1,Amylase increased,17158458,1
19,22.1,Skin discolouration,17158458,1
20,22.1,Hypertension,17158458,1
0,22.1,Madarosis,17158468,3
1,22.1,Pruritus,17158468,3
2,22.1,Alopecia,17158468,3
3,22.1,Fatigue,17158468,3
4,22.1,Glossodynia,17158468,3
0,22.1,Pneumonia,17158472,1
0,22.1,Neoplasm progression,17158476,6
0,22.1,Memory impairment,17158482,6
1,22.1,Headache,17158482,6
0,22.1,Alopecia,17158512,6
1,22.1,Madarosis,17158512,3
0,22.1,White blood cell count decreased,17158529,6
1,22.1,Nasopharyngitis,17158529,6
0,22.1,Neoplasm progression,17158530,6
0,22.1,Burning sensation,17158544,6
1,22.1,Off label use,17158544,6
2,22.1,Product use in unapproved indication,17158544,6
0,22.1,White blood cell count decreased,17158558,1
0,22.1,Bone marrow failure,17158621,2
1,22.1,Platelet count decreased,17158621,2
0,22.1,Myocardial infarction,17158635,6
0,22.1,Pyrexia,17158663,6
1,22.1,Lower respiratory tract infection,17158663,1
2,22.1,Gastrooesophageal reflux disease,17158663,6
3,22.1,Breast cancer recurrent,17158663,6
4,22.1,Contusion,17158663,1
5,22.1,Rash,17158663,1
6,22.1,Pruritus,17158663,1
7,22.1,Upper respiratory tract infection,17158663,6
0,22.1,Diarrhoea,17158683,1
0,22.1,Pancytopenia,17158694,3
1,22.1,Myelodysplastic syndrome,17158694,3
0,22.1,Abdominal distension,17158720,1
1,22.1,Dyspepsia,17158720,1
2,22.1,Fat tissue increased,17158720,1
3,22.1,Myalgia,17158720,1
4,22.1,Gait disturbance,17158720,1
5,22.1,Joint swelling,17158720,1
6,22.1,Tumour marker increased,17158720,1
7,22.1,Fatigue,17158720,1
8,22.1,Blood count abnormal,17158720,1
9,22.1,Alopecia,17158720,1
10,22.1,Decreased appetite,17158720,1
11,22.1,Arthralgia,17158720,1
0,22.1,Sepsis,17158747,5
0,22.1,Metastases to central nervous system,17158782,5
0,22.1,Death,17158787,5
0,22.1,Pleural effusion,17158793,3
0,22.1,Blood creatinine increased,17158794,1
0,22.1,Death,17158814,5
0,22.1,Renal cancer,17158817,5
1,22.1,Malignant neoplasm progression,17158817,5
0,22.1,Arthralgia,17158833,1
1,22.1,Femoral neck fracture,17158833,1
0,22.1,Abdominal pain,17158838,1
0,22.1,Death,17158918,5
0,22.1,Death,17158979,5
0,22.1,Thrombophlebitis,17158989,2
1,22.1,Anaemia,17158989,3
2,22.1,Blood creatinine increased,17158989,3
3,22.1,Pulmonary embolism,17158989,2
0,22.1,Arthralgia,17158992,6
1,22.1,Haemoglobin decreased,17158992,6
2,22.1,Death,17158992,5
3,22.1,Dyspnoea,17158992,2
4,22.1,Pain,17158992,6
5,22.1,Dyspnoea,17158992,6
6,22.1,Back pain,17158992,6
7,22.1,Abdominal pain,17158992,6
8,22.1,Anxiety,17158992,6
9,22.1,Chest pain,17158992,2
10,22.1,Blood pressure increased,17158992,6
11,22.1,Stomatitis,17158992,2
12,22.1,Platelet count decreased,17158992,6
0,22.1,Dyspnoea,17159014,1
1,22.1,Fatigue,17159014,3
2,22.1,Arthralgia,17159014,3
3,22.1,Neutropenia,17159014,1
4,22.1,Cough,17159014,1
5,22.1,Chills,17159014,1
6,22.1,Decreased appetite,17159014,3
7,22.1,Malaise,17159014,1
8,22.1,Musculoskeletal chest pain,17159014,1
9,22.1,Pyrexia,17159014,1
10,22.1,Pneumonia,17159014,1
11,22.1,Diarrhoea,17159014,3
12,22.1,Infusion related reaction,17159014,1
0,22.1,Renal failure,17159018,6
1,22.1,Blood creatinine increased,17159018,6
0,22.1,Asthenia,17159046,3
0,22.1,Nausea,17159057,2
1,22.1,Anaemia,17159057,3
2,22.1,Blood pressure increased,17159057,6
3,22.1,Renal impairment,17159057,3
4,22.1,Diarrhoea,17159057,1
0,22.1,Mucosal inflammation,17159063,1
1,22.1,Hyperpyrexia,17159063,1
0,22.1,Gynaecomastia,17159066,6
1,22.1,Muscular weakness,17159066,3
2,22.1,Weight increased,17159066,3
3,22.1,Breast pain,17159066,3
4,22.1,Breast mass,17159066,3
0,22.1,Neoplasm progression,17159073,6
1,22.1,Pericardial effusion,17159073,6
0,22.1,Death,17159095,5
1,22.1,Asthenia,17159095,
2,22.1,Thrombocytopenia,17159095,
3,22.1,Anaemia,17159095,
0,22.1,Pancytopenia,17159097,2
0,22.1,Vomiting,17159121,6
1,22.1,Blindness,17159121,6
2,22.1,Gait disturbance,17159121,6
3,22.1,Gastric ulcer,17159121,6
4,22.1,Constipation,17159121,6
5,22.1,White blood cell count decreased,17159121,6
6,22.1,Asthenia,17159121,6
0,22.1,Intercepted medication error,17159125,
1,22.1,Syringe issue,17159125,
0,22.1,Needle issue,17159131,
1,22.1,Wrong technique in product usage process,17159131,
2,22.1,Device leakage,17159131,
3,22.1,Intercepted product preparation error,17159131,
0,22.1,Injection site nodule,17159133,6
0,22.1,Device leakage,17159145,
1,22.1,Syringe issue,17159145,
2,22.1,Incorrect dose administered,17159145,
0,22.1,Multiple organ dysfunction syndrome,17159147,5
1,22.1,Neoplasm progression,17159147,5
0,22.1,Product use issue,17159148,6
1,22.1,Product use in unapproved indication,17159148,6
0,22.1,Neutropenia,17159150,6
1,22.1,Stomatitis,17159150,6
2,22.1,Agranulocytosis,17159150,6
0,22.1,Bone marrow failure,17159155,6
1,22.1,Taste disorder,17159155,2
2,22.1,Decreased appetite,17159155,1
3,22.1,Hypotension,17159155,2
4,22.1,Constipation,17159155,2
5,22.1,Back pain,17159155,6
6,22.1,Dizziness,17159155,1
7,22.1,Skin laceration,17159155,2
0,22.1,Metastasis,17159220,
1,22.1,Anaemia,17159220,
2,22.1,Urinary tract infection,17159220,
3,22.1,Thrombocytopenia,17159220,
4,22.1,Circulatory collapse,17159220,
0,22.1,Disease progression,17159240,
0,22.1,Interstitial lung disease,17159242,5
0,22.1,Pulmonary embolism,17159258,1
0,22.1,Pulmonary embolism,17159406,6
1,22.1,Dyspnoea exertional,17159406,2
2,22.1,Hypoxia,17159406,2
3,22.1,Pneumonitis,17159406,2
0,22.1,Intervertebral disc protrusion,17159433,2
1,22.1,Drug eruption,17159433,2
2,22.1,Interstitial lung disease,17159433,3
0,22.1,Death,17159482,5
1,22.1,Product use in unapproved indication,17159482,6
0,22.1,Hyperhidrosis,17159484,1
1,22.1,Dry skin,17159484,6
2,22.1,Blood glucose increased,17159484,6
3,22.1,Taste disorder,17159484,3
4,22.1,Sinusitis,17159484,6
5,22.1,Weight decreased,17159484,6
6,22.1,Blood pressure increased,17159484,6
7,22.1,Fatigue,17159484,3
8,22.1,Underdose,17159484,1
9,22.1,Product dose omission,17159484,6
10,22.1,Malaise,17159484,6
11,22.1,Blood cholesterol abnormal,17159484,6
12,22.1,Alopecia,17159484,3
13,22.1,Gingival disorder,17159484,6
14,22.1,Neuropathy peripheral,17159484,6
15,22.1,Myalgia,17159484,3
16,22.1,Stomatitis,17159484,3
17,22.1,Dental care,17159484,6
18,22.1,Headache,17159484,1
19,22.1,Asthenia,17159484,6
20,22.1,Hair texture abnormal,17159484,6
21,22.1,Memory impairment,17159484,6
22,22.1,Dizziness,17159484,3
23,22.1,Cough,17159484,6
24,22.1,Pruritus,17159484,3
25,22.1,Nausea,17159484,3
0,22.1,Fistula,17159491,6
1,22.1,Surgery,17159491,6
0,22.1,Pruritus,17159494,6
1,22.1,Red blood cell count decreased,17159494,6
2,22.1,Drug ineffective,17159494,6
3,22.1,Petechiae,17159494,6
4,22.1,Platelet count decreased,17159494,1
5,22.1,Photosensitivity reaction,17159494,6
6,22.1,Haemoglobin decreased,17159494,6
7,22.1,Fatigue,17159494,2
0,22.1,Neutropenic infection,17159517,1
1,22.1,Neutropenia,17159517,1
2,22.1,Upper respiratory tract infection,17159517,1
0,22.1,Brain oedema,17159519,2
0,22.1,Immune-mediated hepatitis,17159548,3
1,22.1,Pancytopenia,17159548,3
0,22.1,Vascular purpura,17159566,3
0,22.1,Acute kidney injury,17159569,2
0,22.1,Osteonecrosis,17159595,6
1,22.1,Diarrhoea,17159595,6
0,22.1,Venous thrombosis,17159638,2
1,22.1,Infusion related reaction,17159638,2
0,22.1,Atelectasis,17159640,2
1,22.1,Pneumonia,17159640,2
0,22.1,Skin lesion,17159641,6
1,22.1,Pain in extremity,17159641,6
2,22.1,Pain,17159641,6
3,22.1,Arthralgia,17159641,6
4,22.1,Sluggishness,17159641,6
5,22.1,Seizure,17159641,6
0,22.1,Dizziness,17159648,6
0,22.1,Cerebrovascular accident,17159660,4
0,22.1,Death,17159665,5
0,22.1,Constipation,17159676,2
1,22.1,Hyperbilirubinaemia,17159676,2
2,22.1,Neutropenia,17159676,2
3,22.1,Dyspnoea,17159676,2
0,22.1,Osteonecrosis of jaw,17159732,1
0,22.1,Hot flush,17159759,6
0,22.1,Therapeutic product effect incomplete,17159760,6
1,22.1,Product administration error,17159760,6
0,22.1,Visual acuity reduced,17159761,3
1,22.1,Maculopathy,17159761,3
0,22.1,Limb injury,17159764,6
0,22.1,General physical health deterioration,17159795,3
0,22.1,Hepatotoxicity,17159797,1
0,22.1,Pyrexia,17159823,5
1,22.1,Cerebral infarction,17159823,5
2,22.1,Malignant neoplasm progression,17159823,5
0,22.1,Pulmonary mass,17159831,6
1,22.1,Metastases to lung,17159831,6
2,22.1,Pleural thickening,17159831,6
3,22.1,Disease progression,17159831,6
4,22.1,Metastases to bone,17159831,6
0,22.1,Gastrointestinal haemorrhage,17159858,1
0,22.1,Anxiety,17159872,6
1,22.1,Impaired quality of life,17159872,6
2,22.1,Alopecia,17159872,2
3,22.1,Emotional distress,17159872,6
0,22.1,Pain,17159887,6
1,22.1,Psychological trauma,17159887,6
2,22.1,Alopecia,17159887,2
3,22.1,Impaired quality of life,17159887,6
4,22.1,Anxiety,17159887,6
5,22.1,Emotional distress,17159887,6
0,22.1,Alopecia,17159889,3
1,22.1,Emotional distress,17159889,6
2,22.1,Psychological trauma,17159889,6
0,22.1,Alopecia,17159897,3
1,22.1,Emotional distress,17159897,6
2,22.1,Impaired quality of life,17159897,6
3,22.1,Pain,17159897,6
4,22.1,Anxiety,17159897,6
5,22.1,Psychological trauma,17159897,6
0,22.1,Alopecia,17159902,2
1,22.1,Anxiety,17159902,6
2,22.1,Impaired quality of life,17159902,6
3,22.1,Emotional distress,17159902,6
4,22.1,Pain,17159902,6
0,22.1,Impaired quality of life,17159919,6
1,22.1,Pain,17159919,6
2,22.1,Emotional distress,17159919,6
3,22.1,Anxiety,17159919,6
4,22.1,Alopecia,17159919,3
5,22.1,Psychological trauma,17159919,6
0,22.1,Psychological trauma,17159921,6
1,22.1,Alopecia,17159921,2
0,22.1,Alopecia,17159922,3
1,22.1,Psychological trauma,17159922,6
2,22.1,Emotional distress,17159922,6
0,22.1,Psychological trauma,17159924,6
1,22.1,Anxiety,17159924,6
2,22.1,Pain,17159924,6
3,22.1,Emotional distress,17159924,6
4,22.1,Alopecia,17159924,3
5,22.1,Impaired quality of life,17159924,6
0,22.1,Alopecia,17159950,3
1,22.1,Emotional distress,17159950,6
0,22.1,Alopecia,17159960,2
0,22.1,Pain,17159965,6
1,22.1,Psychological trauma,17159965,6
2,22.1,Alopecia,17159965,2
3,22.1,Anxiety,17159965,6
4,22.1,Impaired quality of life,17159965,6
5,22.1,Emotional distress,17159965,6
0,22.1,Emotional distress,17159967,6
1,22.1,Anxiety,17159967,6
2,22.1,Impaired quality of life,17159967,6
3,22.1,Psychological trauma,17159967,6
4,22.1,Pain,17159967,6
5,22.1,Alopecia,17159967,3
0,22.1,Alopecia,17159986,2
1,22.1,Emotional distress,17159986,6
0,22.1,Alopecia,17159995,3
1,22.1,Emotional distress,17159995,6
2,22.1,Pain,17159995,6
3,22.1,Impaired quality of life,17159995,6
4,22.1,Anxiety,17159995,6
0,22.1,Impaired quality of life,17160000,6
1,22.1,Alopecia,17160000,2
2,22.1,Pain,17160000,6
3,22.1,Anxiety,17160000,6
4,22.1,Emotional distress,17160000,6
0,22.1,Alopecia,17160014,2
1,22.1,Emotional distress,17160014,6
2,22.1,Impaired quality of life,17160014,6
3,22.1,Psychological trauma,17160014,6
4,22.1,Anxiety,17160014,6
5,22.1,Pain,17160014,6
0,22.1,Emotional distress,17160019,6
1,22.1,Psychological trauma,17160019,6
2,22.1,Alopecia,17160019,2
0,22.1,Impaired quality of life,17160024,6
1,22.1,Anxiety,17160024,6
2,22.1,Pain,17160024,6
3,22.1,Alopecia,17160024,2
4,22.1,Emotional distress,17160024,6
0,22.1,Alopecia,17160042,2
0,22.1,Alopecia,17160048,2
1,22.1,Psychological trauma,17160048,6
0,22.1,Alopecia,17160052,2
1,22.1,Anxiety,17160052,6
2,22.1,Impaired quality of life,17160052,6
3,22.1,Pain,17160052,6
4,22.1,Emotional distress,17160052,6
0,22.1,Alopecia,17160066,2
1,22.1,Psychological trauma,17160066,6
0,22.1,Psychological trauma,17160077,6
1,22.1,Alopecia,17160077,2
0,22.1,Emotional distress,17160082,6
1,22.1,Alopecia,17160082,3
0,22.1,Psychological trauma,17160103,6
1,22.1,Alopecia,17160103,2
0,22.1,Alopecia,17160110,2
0,22.1,Impaired quality of life,17160186,6
1,22.1,Anxiety,17160186,6
2,22.1,Psychological trauma,17160186,6
3,22.1,Emotional distress,17160186,6
4,22.1,Alopecia,17160186,2
5,22.1,Pain,17160186,6
0,22.1,Psychological trauma,17160193,6
1,22.1,Alopecia,17160193,2
0,22.1,Respiratory failure,17160204,5
0,22.1,Prostatic specific antigen increased,17160210,6
1,22.1,Off label use,17160210,6
2,22.1,Confusional state,17160210,3
3,22.1,Inappropriate schedule of product administration,17160210,6
0,22.1,Diarrhoea,17160211,1
0,22.1,Blood pressure fluctuation,17160267,6
1,22.1,Tooth injury,17160267,1
2,22.1,Red blood cell count decreased,17160267,6
3,22.1,Abdominal discomfort,17160267,6
4,22.1,Product dose omission,17160267,6
5,22.1,Shoulder deformity,17160267,1
6,22.1,Fall,17160267,1
7,22.1,Carotid artery stenosis,17160267,1
8,22.1,Rib fracture,17160267,1
9,22.1,White blood cell count decreased,17160267,6
0,22.1,Alopecia,17160306,6
0,22.1,Alopecia,17160309,3
1,22.1,Hair colour changes,17160309,3
2,22.1,Hair disorder,17160309,3
3,22.1,Hair texture abnormal,17160309,3
0,22.1,Alopecia,17160310,3
1,22.1,Hair colour changes,17160310,6
2,22.1,Hair disorder,17160310,6
3,22.1,Madarosis,17160310,3
4,22.1,Emotional distress,17160310,6
5,22.1,Hair texture abnormal,17160310,6
0,22.1,Leukopenia,17160311,2
1,22.1,Hot flush,17160311,6
2,22.1,Myalgia,17160311,6
3,22.1,Pain in extremity,17160311,3
0,22.1,Neuropathy peripheral,17160312,6
1,22.1,Nausea,17160312,6
2,22.1,Fatigue,17160312,6
0,22.1,Death,17160314,5
0,22.1,Alopecia,17160321,3
1,22.1,Hair texture abnormal,17160321,3
2,22.1,Hair colour changes,17160321,3
3,22.1,Hair disorder,17160321,3
0,22.1,Hair disorder,17160323,3
1,22.1,Alopecia,17160323,3
2,22.1,Hair colour changes,17160323,3
3,22.1,Hair texture abnormal,17160323,3
0,22.1,Interstitial lung disease,17160335,5
0,22.1,Death,17160341,5
0,22.1,Decreased appetite,17160343,6
1,22.1,Liver abscess,17160343,6
2,22.1,Stomatitis,17160343,6
3,22.1,Metastases to liver,17160343,6
4,22.1,Glucose-6-phosphate dehydrogenase abnormal,17160343,6
5,22.1,Malignant neoplasm progression,17160343,6
0,22.1,Acute kidney injury,17160379,1
0,22.1,Dehydration,17160427,1
1,22.1,Vomiting,17160427,1
2,22.1,Diarrhoea,17160427,1
0,22.1,Metastases to peritoneum,17160438,3
1,22.1,Hyponatraemia,17160438,6
2,22.1,Lung disorder,17160438,5
3,22.1,Cholestasis,17160438,5
4,22.1,Pleural effusion,17160438,3
5,22.1,Alveolar lung disease,17160438,6
6,22.1,Scab,17160438,1
7,22.1,Crepitations,17160438,6
8,22.1,Pulmonary oedema,17160438,3
9,22.1,Hepatic failure,17160438,5
10,22.1,Epistaxis,17160438,1
11,22.1,Metastases to pleura,17160438,3
12,22.1,Peritonitis,17160438,3
13,22.1,Decreased appetite,17160438,6
14,22.1,Stomatitis,17160438,1
15,22.1,Haemothorax,17160438,6
16,22.1,Abdominal pain,17160438,6
17,22.1,Multiple organ dysfunction syndrome,17160438,5
18,22.1,Inflammation,17160438,6
19,22.1,Oedema peripheral,17160438,3
20,22.1,Renal failure,17160438,5
21,22.1,Skin irritation,17160438,1
22,22.1,Septic shock,17160438,3
23,22.1,Hyperkalaemia,17160438,6
24,22.1,Weight decreased,17160438,1
25,22.1,Dyspnoea,17160438,3
26,22.1,Abdominal pain upper,17160438,1
0,22.1,Colony stimulating factor therapy,17160445,6
0,22.1,Malignant neoplasm progression,17160454,6
1,22.1,Colitis,17160454,6
2,22.1,Febrile neutropenia,17160454,6
0,22.1,Inadequate analgesia,17160652,3
1,22.1,Pain,17160652,3
2,22.1,Myoclonus,17160652,3
3,22.1,Constipation,17160652,3
4,22.1,Neurotoxicity,17160652,6
0,22.1,Renal impairment,17160670,6
0,22.1,Loss of consciousness,17160735,6
1,22.1,Movement disorder,17160735,1
2,22.1,Abdominal discomfort,17160735,1
3,22.1,Insomnia,17160735,6
4,22.1,Headache,17160735,3
5,22.1,Migraine,17160735,2
6,22.1,Asthenia,17160735,2
7,22.1,Dizziness,17160735,6
8,22.1,Nausea,17160735,2
0,22.1,Nausea,17160736,3
1,22.1,Thrombocytopenia,17160736,1
2,22.1,Disease progression,17160736,6
3,22.1,Weight decreased,17160736,6
4,22.1,Glomerular filtration rate decreased,17160736,1
5,22.1,Asthenia,17160736,3
6,22.1,Decreased appetite,17160736,3
0,22.1,Urinary tract infection,17160760,2
1,22.1,Dry mouth,17160760,6
2,22.1,Pain in extremity,17160760,6
3,22.1,Vomiting,17160760,1
4,22.1,Oesophageal ulcer,17160760,1
5,22.1,Dehydration,17160760,6
6,22.1,Bone pain,17160760,1
7,22.1,Diarrhoea,17160760,1
8,22.1,Back pain,17160760,3
9,22.1,Blood creatinine increased,17160760,6
10,22.1,Renal failure,17160760,6
11,22.1,Arthralgia,17160760,1
12,22.1,Renal impairment,17160760,6
13,22.1,Fatigue,17160760,2
14,22.1,Hypertension,17160760,2
15,22.1,Miliaria,17160760,6
16,22.1,Abdominal pain upper,17160760,3
0,22.1,Dry mouth,17160776,6
1,22.1,Depression,17160776,6
2,22.1,Metastases to lymph nodes,17160776,6
3,22.1,Drug intolerance,17160776,6
4,22.1,Lymphadenopathy,17160776,6
5,22.1,Weight increased,17160776,6
6,22.1,Listless,17160776,6
7,22.1,Fatigue,17160776,6
8,22.1,Hot flush,17160776,6
9,22.1,Malaise,17160776,6
10,22.1,Metastases to lung,17160776,6
11,22.1,Metastases to bone,17160776,6
12,22.1,Pancreatic mass,17160776,6
13,22.1,Arthralgia,17160776,6
14,22.1,Alopecia,17160776,6
15,22.1,Metastases to abdominal wall,17160776,6
0,22.1,Pyrexia,17160780,1
0,22.1,Chondrocalcinosis,17160784,2
0,22.1,Fatigue,17160787,6
1,22.1,Haemoglobin decreased,17160787,6
2,22.1,Blood creatinine increased,17160787,6
3,22.1,Nephritis,17160787,6
0,22.1,Abdominal pain,17160801,1
0,22.1,Medication error,17160820,1
0,22.1,Drug intolerance,17160823,2
0,22.1,Respiratory tract infection,17160833,1
0,22.1,Overdose,17160839,6
1,22.1,Somnolence,17160839,6
2,22.1,Delirium,17160839,6
3,22.1,Drug ineffective,17160839,6
4,22.1,Depressed level of consciousness,17160839,6
0,22.1,Chronic kidney disease,17160885,6
1,22.1,Proteinuria,17160885,6
0,22.1,Abdominal pain,17161061,6
1,22.1,Death,17161061,5
2,22.1,Dyspnoea,17161061,1
3,22.1,Palpitations,17161061,1
4,22.1,Dry skin,17161061,6
5,22.1,Product use in unapproved indication,17161061,6
0,22.1,Hyperbilirubinaemia,17161136,2
0,22.1,Erythema,17161160,6
1,22.1,Diarrhoea,17161160,6
2,22.1,Rash,17161160,6
0,22.1,General physical health deterioration,17161180,1
1,22.1,Dyspepsia,17161180,1
2,22.1,Leukopenia,17161180,1
3,22.1,Upper respiratory tract infection,17161180,1
4,22.1,Dyspnoea,17161180,1
0,22.1,Infectious pleural effusion,17161195,6
1,22.1,Oesophagopleural fistula,17161195,6
2,22.1,Pyrexia,17161195,6
0,22.1,Weight decreased,17161198,1
1,22.1,Decreased appetite,17161198,1
2,22.1,Diarrhoea,17161198,1
0,22.1,Blood count abnormal,17161234,6
1,22.1,Hypertension,17161234,6
2,22.1,Drug hypersensitivity,17161234,6
0,22.1,Abdominal pain upper,17161240,6
1,22.1,Arthralgia,17161240,6
2,22.1,Nausea,17161240,6
3,22.1,Bronchitis,17161240,6
4,22.1,Pericardial effusion,17161240,6
5,22.1,Cardiac disorder,17161240,3
6,22.1,Anxiety,17161240,6
0,22.1,Death,17161261,5
0,22.1,Neutrophil count decreased,17161476,6
1,22.1,Macrocytosis,17161476,6
2,22.1,Haemoglobin decreased,17161476,6
3,22.1,Red cell distribution width decreased,17161476,6
4,22.1,Blood alkaline phosphatase increased,17161476,6
5,22.1,Red blood cell abnormality,17161476,6
6,22.1,Poikilocytosis,17161476,6
7,22.1,Mean cell volume increased,17161476,6
8,22.1,Lymphocyte count decreased,17161476,6
9,22.1,White blood cell count decreased,17161476,6
10,22.1,Platelet count decreased,17161476,6
11,22.1,Haematocrit decreased,17161476,6
12,22.1,Sinus arrhythmia,17161476,6
13,22.1,Red blood cell count decreased,17161476,6
14,22.1,Decreased immune responsiveness,17161476,6
15,22.1,Anisocytosis,17161476,6
0,22.1,Vertigo,17161485,3
1,22.1,Electrocardiogram T wave abnormal,17161485,1
2,22.1,Musculoskeletal stiffness,17161485,3
3,22.1,Gastrointestinal disorder,17161485,3
4,22.1,Fatigue,17161485,6
5,22.1,Headache,17161485,3
6,22.1,Hot flush,17161485,3
7,22.1,Electrocardiogram repolarisation abnormality,17161485,1
0,22.1,Diarrhoea,17161493,6
1,22.1,Nausea,17161493,6
0,22.1,Asthenia,17161519,6
1,22.1,Malignant neoplasm progression,17161519,6
2,22.1,Breast cancer,17161519,6
3,22.1,Neurotoxicity,17161519,6
4,22.1,Metastases to lung,17161519,6
0,22.1,Breast cancer metastatic,17161520,3
1,22.1,Malignant neoplasm progression,17161520,3
2,22.1,Bone marrow toxicity,17161520,3
0,22.1,Malignant neoplasm progression,17161522,3
1,22.1,Bone marrow toxicity,17161522,3
2,22.1,Breast cancer metastatic,17161522,3
0,22.1,Upper limb fracture,17161533,6
1,22.1,Fall,17161533,1
0,22.1,Breast cancer metastatic,17161542,1
1,22.1,Breast cancer metastatic,17161542,5
0,22.1,Myocardial infarction,17161643,5
0,22.1,Myocardial infarction,17161644,6
0,22.1,Malignant neoplasm progression,17161661,6
0,22.1,Off label use,17161663,6
1,22.1,Necrosis,17161663,1
0,22.1,Fatigue,17161671,6
0,22.1,Gastrointestinal disorder,17161694,2
0,22.1,Dehydration,17161698,5
1,22.1,Abdominal pain,17161698,5
2,22.1,Bradycardia,17161698,5
3,22.1,Hypotension,17161698,5
4,22.1,Diarrhoea,17161698,5
5,22.1,Cardio-respiratory arrest,17161698,5
0,22.1,Dysuria,17161724,6
1,22.1,Abdominal abscess,17161724,6
2,22.1,Disease progression,17161724,6
3,22.1,Suture rupture,17161724,6
4,22.1,Ileus,17161724,6
5,22.1,Stoma site inflammation,17161724,6
6,22.1,Ileus paralytic,17161724,6
7,22.1,Adverse event,17161724,6
8,22.1,Gastrointestinal stoma necrosis,17161724,6
0,22.1,Pulmonary embolism,17161737,5
1,22.1,Malaise,17161737,5
2,22.1,Acute respiratory distress syndrome,17161737,5
3,22.1,Multiple organ dysfunction syndrome,17161737,5
0,22.1,Hyperglycaemia,17161757,4
0,22.1,Liver disorder,17161811,2
0,22.1,Hypotension,17161832,1
1,22.1,Rash,17161832,1
2,22.1,Oxygen saturation decreased,17161832,1
3,22.1,Visual impairment,17161832,1
4,22.1,Pruritus,17161832,1
0,22.1,Tumour ulceration,17161839,2
0,22.1,Gastrointestinal disorder,17161854,6
0,22.1,Respiratory tract infection,17161885,1
0,22.1,Malaise,17161891,6
0,22.1,Electrocardiogram QT prolonged,17161905,2
1,22.1,Nausea,17161905,1
2,22.1,Anaemia,17161905,1
3,22.1,Calcium deficiency,17161905,1
0,22.1,Acute generalised exanthematous pustulosis,17161914,1
0,22.1,Hypersensitivity,17161976,6
0,22.1,Atypical haemolytic uraemic syndrome,17161987,1
1,22.1,Pneumonia,17161987,1
0,22.1,Disease progression,17162029,5
1,22.1,Nausea,17162029,1
2,22.1,Interstitial lung disease,17162029,6
3,22.1,Metastases to bone,17162029,6
4,22.1,Metastases to central nervous system,17162029,6
5,22.1,Vomiting,17162029,1
6,22.1,Platelet count decreased,17162029,1
0,22.1,Myocardial necrosis marker increased,17162092,2
1,22.1,Hepatic function abnormal,17162092,2
0,22.1,Off label use,17162138,6
1,22.1,Death,17162138,5
2,22.1,Intentional product use issue,17162138,6
0,22.1,Pericardial haemorrhage,17162151,6
0,22.1,Circulatory collapse,17162153,1
1,22.1,Presyncope,17162153,1
0,22.1,Cholangitis,17162214,6
0,22.1,Cholangitis sclerosing,17162239,3
1,22.1,Drug-induced liver injury,17162239,3
0,22.1,Dyspnoea,17162254,1
1,22.1,Rash,17162254,1
2,22.1,Drug hypersensitivity,17162254,1
0,22.1,Death,17162267,
0,22.1,Immune thrombocytopenic purpura,17162289,1
0,22.1,Therapy cessation,17162383,
1,22.1,Hospitalisation,17162383,
0,22.1,Death,17162389,
0,22.1,Bone marrow failure,17162402,6
0,22.1,Pain,17162406,1
1,22.1,Urinary tract infection,17162406,6
2,22.1,Intentional product use issue,17162406,6
3,22.1,Fistula,17162406,2
0,22.1,Breast cancer,17162413,5
0,22.1,Death,17162416,5
0,22.1,Sinus tachycardia,17162446,6
1,22.1,Lymphangiosis carcinomatosa,17162446,6
2,22.1,Interstitial lung disease,17162446,1
0,22.1,Adverse drug reaction,17162481,
0,22.1,Thrombosis,17162532,3
1,22.1,Proteinuria,17162532,6
2,22.1,Ovarian cancer,17162532,5
0,22.1,Death,17162533,5
1,22.1,Intentional product use issue,17162533,6
0,22.1,Malignant ascites,17162547,6
1,22.1,Hypertension,17162547,3
2,22.1,Proteinuria,17162547,6
3,22.1,Metastases to peritoneum,17162547,6
0,22.1,Pulmonary fibrosis,17162584,6
0,22.1,Metastases to central nervous system,17162600,6
0,22.1,Constipation,17162605,3
1,22.1,Dehydration,17162605,3
2,22.1,Pyrexia,17162605,3
3,22.1,Oral herpes,17162605,3
4,22.1,Tendon rupture,17162605,3
5,22.1,Nausea,17162605,3
6,22.1,Breast cancer,17162605,3
7,22.1,Hyperglycaemia,17162605,3
8,22.1,Asthenia,17162605,3
9,22.1,Diarrhoea,17162605,3
10,22.1,Fatigue,17162605,3
11,22.1,Malignant neoplasm progression,17162605,3
0,22.1,Bone pain,17162611,
1,22.1,Pneumonia,17162611,
2,22.1,Large intestine infection,17162611,
3,22.1,Nausea,17162611,
0,22.1,Renal impairment,17162659,2
0,22.1,Drug ineffective,17162681,
0,22.1,Pyrexia,17162692,6
1,22.1,Cytopenia,17162692,6
0,22.1,Prostate cancer recurrent,17162698,6
0,22.1,Pulmonary mass,17162713,
0,22.1,Vomiting,17162798,1
1,22.1,Diarrhoea,17162798,1
2,22.1,Acute kidney injury,17162798,1
3,22.1,Drug intolerance,17162798,6
4,22.1,General physical health deterioration,17162798,1
0,22.1,Pancytopenia,17162804,1
0,22.1,Rash erythematous,17162818,1
1,22.1,Skin toxicity,17162818,1
2,22.1,Drug eruption,17162818,1
3,22.1,Acute generalised exanthematous pustulosis,17162818,1
4,22.1,Skin exfoliation,17162818,1
0,22.1,Neutropenia,17162826,1
1,22.1,Malaise,17162826,1
0,22.1,Device related infection,17162854,1
1,22.1,Bacteraemia,17162854,1
0,22.1,Disease progression,17162887,
0,22.1,Large intestine perforation,17162958,4
1,22.1,General physical health deterioration,17162958,1
0,22.1,Drug intolerance,17162973,6
1,22.1,General physical health deterioration,17162973,1
2,22.1,Diarrhoea,17162973,1
3,22.1,Acute kidney injury,17162973,1
4,22.1,Vomiting,17162973,1
0,22.1,Flushing,17163029,2
1,22.1,Chest discomfort,17163029,2
2,22.1,Dyspnoea at rest,17163029,2
3,22.1,"Hallucination, visual",17163029,2
0,22.1,Death,17163121,5
0,22.1,Toothache,17163154,6
0,22.1,Subcutaneous haematoma,17163157,2
0,22.1,Diarrhoea,17163165,1
1,22.1,Rectal haemorrhage,17163165,1
2,22.1,Abdominal pain upper,17163165,1
0,22.1,Rash pruritic,17163193,2
0,22.1,Glomerulonephritis rapidly progressive,17163215,2
0,22.1,Retinopathy,17163234,6
0,22.1,Asthenia,17163244,6
1,22.1,Device related infection,17163244,1
2,22.1,Bacteraemia,17163244,1
3,22.1,Weight decreased,17163244,6
0,22.1,Cardiomyopathy,17163250,3
1,22.1,Ejection fraction decreased,17163250,3
0,22.1,Fatigue,17163254,1
1,22.1,Diarrhoea,17163254,1
0,22.1,Death,17163261,5
1,22.1,Atrial fibrillation,17163261,6
2,22.1,Pulmonary oedema,17163261,6
3,22.1,Product dose omission,17163261,6
4,22.1,Cerebrovascular accident,17163261,6
5,22.1,Product availability issue,17163261,6
0,22.1,Gastrointestinal disorder,17163304,3
1,22.1,Abdominal distension,17163304,3
2,22.1,Flatulence,17163304,3
0,22.1,Death,17163339,5
0,22.1,Upper limb fracture,17163407,6
1,22.1,Fall,17163407,6
2,22.1,Lower gastrointestinal haemorrhage,17163407,2
0,22.1,Off label use,17163408,
1,22.1,Hospitalisation,17163408,3
0,22.1,Acute kidney injury,17163413,1
0,22.1,Headache,17163428,6
1,22.1,Hypotension,17163428,5
2,22.1,Brain neoplasm,17163428,5
3,22.1,Vertigo,17163428,6
4,22.1,Metastasis,17163428,5
0,22.1,Inappropriate antidiuretic hormone secretion,17163467,6
1,22.1,Death,17163467,5
2,22.1,Paraparesis,17163467,6
3,22.1,Hypokalaemia,17163467,6
4,22.1,Leukopenia,17163467,6
5,22.1,Malignant neoplasm progression,17163467,6
6,22.1,Delirium,17163467,6
7,22.1,Metastases to meninges,17163467,6
8,22.1,Fatigue,17163467,6
9,22.1,Hyponatraemia,17163467,6
10,22.1,Dermatitis,17163467,6
0,22.1,Anaemia,17163501,6
1,22.1,Globulins decreased,17163501,6
2,22.1,Gastric ulcer,17163501,6
0,22.1,Death,17163518,5
0,22.1,Death,17163538,5
0,22.1,Atrioventricular block complete,17163588,1
0,22.1,Death,17163621,5
0,22.1,Death,17163663,5
0,22.1,Gait disturbance,17163664,3
1,22.1,Thrombosis,17163664,3
0,22.1,Death,17163672,5
0,22.1,Back pain,17163675,1
1,22.1,Erythema,17163675,1
2,22.1,Product use in unapproved indication,17163675,1
3,22.1,Off label use,17163675,1
4,22.1,Chest discomfort,17163675,1
5,22.1,Dyspnoea,17163675,1
6,22.1,Flushing,17163675,1
0,22.1,Breast cancer metastatic,17163692,5
1,22.1,Endocarditis,17163692,5
2,22.1,Acute respiratory distress syndrome,17163692,5
3,22.1,Aortic valve incompetence,17163692,5
4,22.1,Pneumonitis,17163692,5
0,22.1,Death,17163746,5
0,22.1,Death,17163752,5
0,22.1,Hypertension,17163786,1
0,22.1,Malignant neoplasm progression,17163850,6
1,22.1,Breast cancer,17163850,6
2,22.1,Death,17163850,5
0,22.1,Nausea,17163853,6
1,22.1,Off label use,17163853,6
2,22.1,Diarrhoea,17163853,6
3,22.1,Nausea,17163853,6
4,22.1,Palmar-plantar erythrodysaesthesia syndrome,17163853,6
0,22.1,Sequestrectomy,17163857,1
1,22.1,Osteonecrosis of jaw,17163857,6
2,22.1,Tooth extraction,17163857,1
3,22.1,Loose tooth,17163857,1
4,22.1,Osteonecrosis of jaw,17163857,1
0,22.1,Tubulointerstitial nephritis,17163881,3
0,22.1,Hyperglycaemic hyperosmolar nonketotic syndrome,17163906,4
1,22.1,Diarrhoea,17163906,4
0,22.1,Behaviour disorder,17163907,6
1,22.1,Anaemia,17163907,6
2,22.1,Asthenia,17163907,6
3,22.1,Hyperintensity in brain deep nuclei,17163907,2
4,22.1,Cerebral disorder,17163907,2
5,22.1,Hypometabolism,17163907,6
6,22.1,Thrombocytopenia,17163907,6
7,22.1,Coma,17163907,5
8,22.1,Acute myeloid leukaemia,17163907,5
9,22.1,Haemoglobinaemia,17163907,6
10,22.1,Dyspnoea exertional,17163907,6
11,22.1,Limbic encephalitis,17163907,5
12,22.1,Neutropenia,17163907,6
13,22.1,"Hallucination, auditory",17163907,6
0,22.1,Taste disorder,17163923,6
1,22.1,Bone pain,17163923,6
2,22.1,Neutropenia,17163923,2
0,22.1,Neuropathy peripheral,17163925,6
1,22.1,Drug intolerance,17163925,6
2,22.1,Breast cancer,17163925,6
3,22.1,Malignant neoplasm progression,17163925,6
0,22.1,Erythema,17163928,1
1,22.1,Face oedema,17163928,1
0,22.1,Metastases to liver,17163939,6
1,22.1,Ovarian cancer recurrent,17163939,3
2,22.1,Disease progression,17163939,6
3,22.1,Urogenital fistula,17163939,3
4,22.1,Malignant ascites,17163939,6
0,22.1,Pruritus,17164029,1
1,22.1,Injection site irritation,17164029,1
0,22.1,Hereditary motor and sensory neuropathy,17164043,1
1,22.1,Condition aggravated,17164043,1
0,22.1,Headache,17164065,3
1,22.1,Fatigue,17164065,3
2,22.1,Vomiting,17164065,6
3,22.1,Platelet count decreased,17164065,3
4,22.1,Asthenia,17164065,6
5,22.1,White blood cell count decreased,17164065,3
6,22.1,Urinary tract infection,17164065,6
7,22.1,Brain neoplasm,17164065,6
8,22.1,Oral mucosal blistering,17164065,6
9,22.1,Abdominal discomfort,17164065,6
10,22.1,Stomatitis,17164065,3
0,22.1,Fatigue,17164092,6
0,22.1,Infection,17164136,3
1,22.1,Dyspnoea,17164136,3
0,22.1,Tumour marker increased,17164176,6
1,22.1,Malaise,17164176,6
2,22.1,Hepatic function abnormal,17164176,6
3,22.1,Pyrexia,17164176,6
0,22.1,Neuropathy peripheral,17164197,6
0,22.1,Lung disorder,17164198,6
0,22.1,Hypoacusis,17164206,6
1,22.1,Product use issue,17164206,6
2,22.1,Off label use,17164206,6
0,22.1,Joint swelling,17164245,6
1,22.1,Gastrointestinal disorder,17164245,6
2,22.1,Neoplasm progression,17164245,6
0,22.1,Blood count abnormal,17164247,1
0,22.1,Cough,17164249,6
1,22.1,Increased upper airway secretion,17164249,6
2,22.1,Sinus disorder,17164249,6
3,22.1,Nasopharyngitis,17164249,6
0,22.1,White blood cell count decreased,17164251,6
1,22.1,Red blood cell count decreased,17164251,6
2,22.1,Dry skin,17164251,6
3,22.1,Alopecia,17164251,6
4,22.1,Fatigue,17164251,6
5,22.1,Asthenia,17164251,6
6,22.1,Sinusitis,17164251,6
7,22.1,Vision blurred,17164251,6
8,22.1,Weight decreased,17164251,6
0,22.1,Incontinence,17164280,6
1,22.1,Urinary tract infection,17164280,1
2,22.1,Haemorrhage,17164280,6
0,22.1,Heart rate decreased,17164281,1
1,22.1,Fatigue,17164281,2
2,22.1,Blood pressure increased,17164281,1
0,22.1,Localised oedema,17164296,6
1,22.1,Intestinal obstruction,17164296,6
2,22.1,Product dose omission,17164296,6
0,22.1,Death,17164307,5
0,22.1,Second primary malignancy,17164309,6
1,22.1,Pyrexia,17164309,6
2,22.1,Metastatic renal cell carcinoma,17164309,6
3,22.1,Seizure,17164309,6
0,22.1,Fatigue,17164320,2
0,22.1,Fatigue,17164356,1
1,22.1,Confusional state,17164356,1
2,22.1,Blood count abnormal,17164356,1
3,22.1,Hallucination,17164356,1
4,22.1,Nausea,17164356,1
0,22.1,Colitis,17164365,6
1,22.1,Diarrhoea,17164365,6
2,22.1,Diverticulitis,17164365,6
3,22.1,Inflammation,17164365,6
0,22.1,Anaphylactic shock,17164380,1
0,22.1,Lower limb fracture,17164395,3
0,22.1,Dementia,17164401,1
0,22.1,White blood cell count abnormal,17164410,6
0,22.1,Pruritus,17164422,1
1,22.1,Iron deficiency anaemia,17164422,6
2,22.1,Gastritis,17164422,6
3,22.1,Abdominal pain upper,17164422,6
4,22.1,Vulvovaginal candidiasis,17164422,2
5,22.1,Oedema peripheral,17164422,6
0,22.1,Drug ineffective,17164454,6
1,22.1,Condition aggravated,17164454,6
0,22.1,Hair disorder,17164459,3
1,22.1,Alopecia,17164459,3
2,22.1,Hair texture abnormal,17164459,3
3,22.1,Hair colour changes,17164459,3
4,22.1,Madarosis,17164459,3
0,22.1,Nausea,17164464,6
0,22.1,Flushing,17164473,1
1,22.1,Nausea,17164473,1
2,22.1,Abdominal pain,17164473,1
0,22.1,Hair disorder,17164477,3
1,22.1,Alopecia,17164477,3
2,22.1,Madarosis,17164477,3
3,22.1,Hair texture abnormal,17164477,3
4,22.1,Hair colour changes,17164477,3
0,22.1,Flushing,17164478,1
1,22.1,Dyspnoea,17164478,1
0,22.1,Fall,17164485,6
1,22.1,Hypoaesthesia,17164485,6
2,22.1,Full blood count decreased,17164485,6
3,22.1,Alopecia,17164485,6
4,22.1,Hip fracture,17164485,6
5,22.1,Neoplasm progression,17164485,6
6,22.1,Neuralgia,17164485,6
7,22.1,Vision blurred,17164485,6
8,22.1,Cataract,17164485,6
0,22.1,Tooth fracture,17164488,3
1,22.1,Tooth loss,17164488,3
0,22.1,Hair texture abnormal,17164498,3
1,22.1,Hair colour changes,17164498,3
2,22.1,Alopecia,17164498,3
3,22.1,Hair disorder,17164498,3
4,22.1,Madarosis,17164498,3
0,22.1,Chest pain,17164507,2
1,22.1,Musculoskeletal pain,17164507,1
0,22.1,Product dispensing error,17164515,6
0,22.1,Hair colour changes,17164529,3
1,22.1,Madarosis,17164529,3
2,22.1,Hair disorder,17164529,3
3,22.1,Alopecia,17164529,3
4,22.1,Hair texture abnormal,17164529,3
0,22.1,Alopecia,17164531,3
1,22.1,Hair disorder,17164531,3
2,22.1,Hair colour changes,17164531,3
3,22.1,Depression,17164531,6
4,22.1,Anxiety,17164531,6
5,22.1,Hair texture abnormal,17164531,3
6,22.1,Madarosis,17164531,3
0,22.1,Depression,17164537,6
1,22.1,Alopecia,17164537,3
2,22.1,Hair texture abnormal,17164537,3
3,22.1,Madarosis,17164537,3
4,22.1,Hair colour changes,17164537,3
5,22.1,Hair disorder,17164537,3
0,22.1,Hair colour changes,17164543,3
1,22.1,Depression,17164543,6
2,22.1,Hair texture abnormal,17164543,3
3,22.1,Alopecia,17164543,3
4,22.1,Madarosis,17164543,3
5,22.1,Anxiety,17164543,6
6,22.1,Hair disorder,17164543,3
0,22.1,Hepatic cancer,17164579,6
1,22.1,Neutropenia,17164579,6
2,22.1,Anaemia,17164579,6
3,22.1,Second primary malignancy,17164579,6
0,22.1,Blood pressure increased,17164648,6
1,22.1,Abdominal pain upper,17164648,1
0,22.1,Thrombocytopenia,17164650,6
1,22.1,Anaemia,17164650,6
2,22.1,Leukopenia,17164650,6
3,22.1,Death,17164650,5
0,22.1,Headache,17164653,2
1,22.1,Platelet count decreased,17164653,2
2,22.1,Immunosuppression,17164653,2
3,22.1,Asthenia,17164653,2
4,22.1,Protein total increased,17164653,2
5,22.1,Meningoencephalitis herpetic,17164653,2
6,22.1,Neoplasm progression,17164653,2
0,22.1,Lung disorder,17164716,2
1,22.1,Clostridium difficile colitis,17164716,2
0,22.1,Anaemia,17164762,1
1,22.1,Pneumonitis,17164762,4
0,22.1,Encephalitis,17164808,2
1,22.1,Fall,17164808,2
2,22.1,Colitis,17164808,6
3,22.1,Electroencephalogram abnormal,17164808,2
4,22.1,Meningitis,17164808,2
0,22.1,Hypocalcaemia,17164910,1
1,22.1,Renal tubular disorder,17164910,3
0,22.1,Fatigue,17164913,3
1,22.1,Hypertension,17164913,6
2,22.1,Constipation,17164913,1
3,22.1,Oedema peripheral,17164913,6
4,22.1,Decreased appetite,17164913,6
5,22.1,Intra-abdominal fluid collection,17164913,6
6,22.1,Abdominal discomfort,17164913,1
7,22.1,Death,17164913,5
8,22.1,Nausea,17164913,3
0,22.1,Nausea,17164917,3
1,22.1,Fatigue,17164917,3
2,22.1,Surgery,17164917,3
0,22.1,Chest discomfort,17164923,1
1,22.1,Feeling hot,17164923,1
2,22.1,Flushing,17164923,1
0,22.1,Death,17164926,5
0,22.1,Dyspnoea,17164947,3
1,22.1,Erythema,17164947,3
2,22.1,Nausea,17164947,3
3,22.1,Unresponsive to stimuli,17164947,3
0,22.1,Cough,17164948,6
1,22.1,Pubis fracture,17164948,6
0,22.1,Overdose,17164954,6
0,22.1,Back pain,17164956,1
1,22.1,Oxygen saturation decreased,17164956,1
2,22.1,Bronchospasm,17164956,1
3,22.1,Flushing,17164956,1
0,22.1,Feeling hot,17164957,1
0,22.1,Death,17164960,5
0,22.1,Cardiac failure,17164962,1
0,22.1,Death,17164983,5
0,22.1,Chest discomfort,17165013,2
1,22.1,Asthenia,17165013,2
2,22.1,Off label use,17165013,
0,22.1,Death,17165016,5
1,22.1,Nausea,17165016,1
0,22.1,Dehydration,17165021,3
1,22.1,General physical condition abnormal,17165021,3
0,22.1,Dizziness,17165029,1
1,22.1,Abdominal pain,17165029,3
2,22.1,Hypertension,17165029,2
3,22.1,Fatigue,17165029,2
4,22.1,Nausea,17165029,1
5,22.1,Diarrhoea haemorrhagic,17165029,1
6,22.1,Taste disorder,17165029,2
7,22.1,Weight decreased,17165029,3
8,22.1,Abdominal pain,17165029,1
9,22.1,Diarrhoea,17165029,1
0,22.1,Death,17165030,5
0,22.1,Pneumonia,17165035,5
1,22.1,Hyponatraemia,17165035,2
2,22.1,Decreased appetite,17165035,1
3,22.1,Cytomegalovirus test positive,17165035,1
4,22.1,Cytomegalovirus test positive,17165035,6
5,22.1,Fungal test positive,17165035,6
0,22.1,Hypertensive crisis,17165053,6
0,22.1,No adverse event,17165057,3
0,22.1,Fatigue,17165123,
1,22.1,Sepsis,17165123,
2,22.1,Nausea,17165123,
0,22.1,Kidney transplant rejection,17165254,6
0,22.1,Death,17165255,5
1,22.1,Renal failure,17165255,
2,22.1,Haematuria,17165255,
3,22.1,Oliguria,17165255,
0,22.1,General physical health deterioration,17165274,3
0,22.1,Febrile bone marrow aplasia,17165285,1
1,22.1,Diarrhoea,17165285,1
0,22.1,Febrile neutropenia,17165291,5
0,22.1,Neutropenia,17165301,1
1,22.1,Drug interaction,17165301,6
0,22.1,Hysterectomy,17165317,6
1,22.1,Product use in unapproved indication,17165317,6
0,22.1,Osteonecrosis of jaw,17165345,3
0,22.1,Hepatobiliary disease,17165393,2
0,22.1,Death,17165444,5
1,22.1,Product dose omission,17165444,1
2,22.1,Malaise,17165444,6
